JBiSE  Vol.8 No.9 , September 2015
The Influence of Leukocyte and Platelet Concentrate Enrich in Stem Cells on Bone Regeneration Processes: A Clinical and Flow Cytometry Study
ABSTRACT
This article reports the efficacy of percutaneous autologous leukocyte- and platelet-rich plasma (L-PRP) injection into delayed union site as a minimally invasive method alternative to bone marrow aspirate and open grafting techniques. Each of 15 participants was followed on a regular basis with clinical examinations, roentgenograms. The average time to union was 8.4 weeks after L-PRP injection and the union was achieved in all cases. CD34+/45+ cells counts were increased by 410% and CD34+/45- cells counts were increased by 488% on average in L-PRP. Our investigation showed that L-PRP enrich in stem cells can produce the desired stimulatory response despite a substantial amount of vital bone cells from mesenchymal line. We believe that the using of L-PRP enriched in stem cells, growth factors and antimicrobial proteins might be a promising treatment method in regenerative medicine.

Cite this paper
Bielecki, T. , Wójcik, K. , Bold, T. , Osadnik, B. and Szczepański, T. (2015) The Influence of Leukocyte and Platelet Concentrate Enrich in Stem Cells on Bone Regeneration Processes: A Clinical and Flow Cytometry Study. Journal of Biomedical Science and Engineering, 8, 659-664. doi: 10.4236/jbise.2015.89062.
References
[1]   Dohan Ehrenfest, D.M., Bielecki, T., Mishra, A., Borzini, P., Inchingolo, F., Sammartino, G., Rasmusson, L. and Evert, P.A. (2012) In Search of a Consensus Terminology in the Field of Platelet Concentrates for Surgical Use: Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), Fibrin Gel Polymerization and Leukocytes. Current Pharmaceutical Biotechnology, 13, 1131-1137.
http://dx.doi.org/10.2174/138920112800624328

[2]   Bielecki, T. and Dohan Ehrenfest, D.M. (2012) Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF): Surgical Adjuvants, Preparations for in Situ Regenerative Medicine and Tools for Tissue Engineering. Current Pharmaceutical Biotechnology, 13, 1121-1130.
http://dx.doi.org/10.2174/138920112800624292

[3]   Cieslik-Bielecka, A., Choukroun, J., Odin, G. and Dohan Ehrenfest, D.M. (2012) L-PRP/L-PRF in Esthetic Plastic Surgery, Regenerative Medicine of the Skin and Chronic Wounds. Current Pharmaceutical Biotechnology, 13, 1266- 1277.
http://dx.doi.org/10.2174/138920112800624463

[4]   Clark, R.A. (2001) Fibrin and Wound Healing. Annals of the New York Academy of Sciences, 936, 355-367.
http://dx.doi.org/10.1111/j.1749-6632.2001.tb03522.x

[5]   Gibble, J.W. and Ness, P.M. (1990) Fibrin Glue: The Perfect Operative Sealant? Transfusion, 30, 741-747.
http://dx.doi.org/10.1046/j.1537-2995.1990.30891020337.x

[6]   Del Corso, M., Vervelle, A., Simonpieri, A., et al. (2012) Current Knowledge and Perspectives for the Use of Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) in Oral and Maxillofacial Surgery Part 1: Periodontal and Dentoalveolar Surgery. Current Pharmaceutical Biotechnology, 13, 1207-1230.
http://dx.doi.org/10.2174/138920112800624391

[7]   Bielecki, T.M. and Gazdzik, T.S. (2006) Percutaneous Injection of Autogenous Growth Factors in Patient with Nonunion of the Humerus. A Case Report. Journal of Orthopaedics, 3, e15.

[8]   Mishara, A. and Pavelko, T. (2006) Treatment of Chronic Elbow Tendinosis with Buffered Platelet-Rich Plasma. The American Journal of Sports Medicine, 34, 1774-1778.
http://dx.doi.org/10.1177/0363546506288850

[9]   Marx, R.E., Carlson, E.R., Eichstaedt, R.M., Schimmele, S.R., Strauss, J.E. and Georgeff, K.R. (1998) Platelet-Rich Plasma: Growth Factor Enhancement for Bone Grafts. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 85, 638-646.
http://dx.doi.org/10.1016/S1079-2104(98)90029-4

[10]   Bielecki, T.M. and Gazdzik, T.S. (2007) Percutaneous Injection of Autologous Platelet-Rich Gel in a Patient with an Infected Nonunion of the Tibia. A Case Report and Review of the Literature. Journal of Orthopaedics Trauma Surgery and Related Research, 2, s69-s72.

[11]   Moojen, D.J., Everts, P.A., Schure, R.M., Overdevest, E.P., van Zundert, A., et al. (2008) Antimicrobial Activity of Platelet-Leukocyte Gel against Staphylococcus Aureus. Journal of Orthopaedic Research, 26, 404-410.
http://dx.doi.org/10.1002/jor.20519

[12]   Weibrich, G., Hansen, T., Kleis, W., Buch, R. and Hitzler, W.E. (2004) Effect of Platelet Concentration in Platelet- Rich Plasma on Peri-Implant Bone Regeneration. Bone, 34, 665-671.
http://dx.doi.org/10.1016/j.bone.2003.12.010

[13]   Mishra, A., Harmon, K., Woodall, J. and Vieira, A. (2012) Sports Medicine Applications of Platelet Rich Plasma. Current Pharmaceutical Biotechnology, 13, 1185-1195.
http://dx.doi.org/10.2174/138920112800624283

[14]   Anitua, E., Sanchez, M., Orive, G. and Andia, I. (2007) The Potential Impact of the Preparation Rich in Growth Factors (PRGF) in Different Medical Fields. Biomaterials, 28, 4551-4560.
http://dx.doi.org/10.1016/j.biomaterials.2007.06.037

[15]   Toeroek, R. and Dohan Ehrenfest, D.M. (2013) The Concept of Screw-Guided Bone Regeneration (S-GBR). Part 2: S- GBR in the Severely Resorbed Preimplant Posterior Mandible Using Bone Xenograft and Leukocyte- and Platelet-Rich Fibrin (L-PRF): A 5-Year Follow-Up. POSEIDO, 1, 85-92.

[16]   Cieslik-Bielecka, A., Choukroun, J., Odin, G. and Dohan Ehrenfest, D.M. (2012) L-PRP/L-PRF in Esthetic Plastic Surgery, Regenerative Medicine of the Skin and Chronic Wounds. Current Pharmaceutical Biotechnology, 13, 1266-1277.
http://dx.doi.org/10.2174/138920112800624463

[17]   Everts, P.A., Hoffmann, J., Weibrich, G., Mahoney, C.B., Schonberger, J.P.A.M., et al. (2006) Differences in Platelet Growth Factor Release and Leucocyte Kinetics during Autologous Platelet Gel Formation. Transfusion Medicine, 16, 363-368.
http://dx.doi.org/10.1111/j.1365-3148.2006.00708.x

[18]   Everts, P.A., van Zundert, A., Schonberger, J.P., Devilee, R.J. and Knape, J.T. (2008) What Do We Use: Platelet-Rich Plasma or Platelet-Leukocyte Gel? Journal of Biomedical Materials Research Part A, 85, 1135-1136.
http://dx.doi.org/10.1002/jbm.a.31570

[19]   Cieslik, T., Skowronek, J., Cieslik, M. and Cieslik-Bielecka, A. (2009) Bone Graft Application from Anterior Sinus Maxillary Wall in Orbital Floor Reconstruction. Journal of Craniofacial Surgery, 20, 512-515.
http://dx.doi.org/10.1097/SCS.0b013e31818436a5

[20]   Malhotra, A., Pelletier, M.H., Yu, Y. and Walsh, W.R. (2013) Can Platelet-Rich Plasma (PRP) Improve Bone Healing? A Comparison between the Theory and Experimental Outcomes. Archives of Orthopaedic and Trauma Surgery, 133, 153-165.
http://dx.doi.org/10.1007/s00402-012-1641-1

[21]   Frechette, J.P., Martineau, I. and Gagnon, G. (2005) Platelet Rich Plasmas: Growth Factor Content and Roles in Wound Healing. Journal of Dental Research, 84, 434-439.
http://dx.doi.org/10.1177/154405910508400507

[22]   Yuan, T., Zhang, C. and Zeng, B. (2008) Treatment of Chronic Femoral Osteomyelitis with Platelet-Rich Plasma (PRP): A Case Report. Transfusion and Apheresis Science, 38, 167-173.
http://dx.doi.org/10.1016/j.transci.2008.01.006

[23]   Everts, P.A., Devilee, R.J., Brown Mahoney, C., van Erp, A., Oosterbos, C.J., Stellenboom, M., Knape, J.T. and van Zundert, A. (2008) Exogenous Application of Platelet-Leukocyte Gel during Open Subacromial Decompression Contributes to Improved Patient Outcome. A Prospective Randomized Double-Blind Study. European Surgical Research, 40, 203-210.
http://dx.doi.org/10.1159/000110862

[24]   Khalafi, R.S., Bradford, D.W. and Wilson, M.G. (2008) Topical Application of Autologous Blood Products during Surgical Closure Following a Coronary Artery Bypass Graft. European Journal Cardio-Thoracic Surgery, 34, 360-364.
http://dx.doi.org/10.1016/j.ejcts.2008.04.026

[25]   Aspenberg, P. and Virchenko, O. (2004) Platelet Concentrate Injection Improves Achilles Tendon Repair in Rats. Acta Orthopaedica Scandinavica, 75, 93-99.
http://dx.doi.org/10.1080/00016470410001708190

[26]   Bielecki, T., Gazdzik, T.S. and Szczepanski, T. (2006) What Do We Use: Platelet-Rich Plasma or Platelet-Rich Gel? Bone, 39, 1388,.
http://dx.doi.org/10.1016/j.bone.2006.06.015

[27]   Bielecki, T., Gazdzik, T.S and Szczepanski, T. (2008) Benefit of Percutaneous Injection of Autologous Platelet-Leukocyte-Rich Gel in Patients with Delayed Union and Nonunion. European Surgical Research, 40, 289-296.
http://dx.doi.org/10.1159/000114967

[28]   Lowery, G.L., Kulkarni, S. and Pennisi, A.E. (1999) Use of Autologous Growth Factors in Lumbar Spinal Fusion. Bone, 25, 47S-50S.
http://dx.doi.org/10.1016/S8756-3282(99)00132-5

[29]   Kitoh, H., Kitakoji, T., Tsuchiya, H., Katoh, M. and Ishiguro, N. (2007) Transplantation of Culture Expanded Bone Marrow Cells and Platelet Rich Plasma in Distraction Osteogenesis of the Long Bones. Bone, 40, 522-528.
http://dx.doi.org/10.1016/j.bone.2006.09.019

[30]   Bielecki, T., Cieslik-Bielecka, A., Zelawski, M. and Mikusek, W. (2012) A Side-Effect Induced by the Combination of a Demineralized Freeze-Dried Bone Allograft and Leucocyte and Platelet-Rich Plasma during Treatment for Large Bone Cysts: A 4-Year Follow-Up Clinical Study. Transfusion and Apheresis Science, 47, 133-138.
http://dx.doi.org/10.1016/j.transci.2012.06.017

[31]   Seaberg, R.M. and van der Kooy, D. (2003) Stem and Progenitor Cells: The Premature Desertion of Rigorous Definitions. Trends in Neurosciences, 26, 125-131.
http://dx.doi.org/10.1016/S0166-2236(03)00031-6

[32]   Ciurea, M.E., Georgescu, A.M., Purcaru, S.O., Artene, S.A., Emami, G.H., Boldeanu, M.V., Tache, D.E. and Dricu, A. (2014) Cancer Stem Cells: Biological Functions and Therapeutically Targeting. International Journal of Molecular, 15, 8169-8185.
http://dx.doi.org/10.3390/ijms15058169

 
 
Top